|First-year experiences with the Interagency Guidelines for Drug Donations (WHO/EDM, 2000, 51 p.)|
|4. Basic characteristics of drug donations|
The total value of donations reported by the donors in this study was US$ 298 million - 14 industry donors contributed US$ 228 million (76%), 11 non-governmental organizations contributed US$ 68 million (23%) and governmental agencies contributed US$ 3 million (1%). Consolidators represented in this study reported donations totalling US$ 360 million.
There were huge differences in size between amounts donated by the various donors. For example, one pharmaceutical industry donor reported annual donations of US$ 170 million, which is 74% of all industry donors. The four largest donors (with US$ 170, 18, 15 and 11 million) constitute 94% of industry donations. The situation is similar with regard to consolidators. With a reported annual turnover of US$ 148 and 141 million, the two largest consolidators constitute 80% of all consolidators.
Soft loans by the World Bank as well as the many ongoing bilateral drug donations by the Governments of Denmark, the Netherlands, Sweden and other countries are not included in this overview. The former are estimated at about US$ 300 million a year, while the latter are not really known but can be estimated at several tens of millions of dollars per government per year. These are all donations of procured drugs (usually through tender).